[1]盛 强,王晓颖,张艳林,等.“秩边透水道”针法治疗肾虚型早发性卵巢功能不全临床研究[J].陕西中医,2024,(2):260-263.[doi:DOI:10.3969/j.issn.1000-7369.2024.02.025]
　SHENG Qiang,WANAG Xiaoying,ZHANG Yanlin,et al.Clinical study on the treatment of premature ovarian insufficiency of kidney deficiency type with “Zhibian(BL54)to Shuidao(ST28)”[J].,2024,(2):260-263.[doi:DOI:10.3969/j.issn.1000-7369.2024.02.025]
点击复制

“秩边透水道”针法治疗肾虚型早发性卵巢功能不全临床研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2024年2期
页码:
260-263
栏目:
针灸经络
出版日期:
2024-02-05

文章信息/Info

Title:
Clinical study on the treatment of premature ovarian insufficiency of kidney deficiency type with “Zhibian(BL54)to Shuidao(ST28)”
作者:
盛 强1; 王晓颖1; 张艳林2; 张超凤3; 陈晓燕1; 曹玉霞1; 闫 敏1; 冀来喜4; 王海军4
(1.山西省针灸医院,山西 太原 030006; 2.天津中医药大学,天津 301617; 3.北京市丰台区方庄社区卫生服务中心,北京 100078; 4.山西中医药大学,山西 晋中 030619)
Author(s):
SHENG Qiang; WANAG Xiaoying; ZHANG Yanlin; ZHANG Chaofeng; CHEN Xiaoyan; CAO Yuxia; YAN Min; JI Laixi; WANG Haijun
(Acupuncture and Moxibustion Hospital of Shanxi Province,Taiyuan 030006,China)
关键词:
早发性卵巢功能不全;  “秩边透水道”针法;  卵巢早衰;  肾虚型;  雌孕激素序贯疗法;  太溪
Keywords:
Premature ovarian insufficiency;  Zhibian(BL54)to Shuidao(ST28);  Premature ovarian failure;  Kidney deficiency;  Hormone replacement therapy;  Taixi
分类号:
R 711.75
DOI:
DOI:10.3969/j.issn.1000-7369.2024.02.025
文献标志码:
A
摘要:
目的:观察“秩边透水道”针法治疗肾虚型早发性卵巢功能不全(POI)的临床疗效。方法:将62例POI患者随机分成观察组和对照组,每组31例。观察组用“秩边透水道”针法,配伍太溪、命门,隔日针刺1次,每次留针30 min,对照组采用雌孕激素序贯疗法(HRT),两组均以4周为1个疗程,治疗3个疗程,记录并比较治疗前后两组患者的中医症候积分、血清中促卵泡生成素(FSH)、雌二醇(E2)水平的变化,并对两种疗法的安全性进行评价。结果:与治疗前比较,治疗后两组患者的中医症候积分均降低(P<0.05),且观察组对中医症候的改善优于对照组(P<0.05); FSH水平均下降(P<0.05),E2水平均升高(P<0.05),组间比较差异均无统计学意义(P>0.05); 观察组总有效率为90.32%,高于对照组的65.52%(P<0.05),观察组不良事件发生率为3.23%,低于对照组的24.14%(P<0.05)。结论:“秩边透水道”针法能够有效治疗POI,而且在改善肾虚型临床症状和安全性方面较对照组更具有优势。
Abstract:
Objective:To study the clinical efficacy of “Zhibian(BL54)to Shuidao(ST28)” for the patients with the premature ovarian insufficience(kidney deficiency type).Methods:62 patients were randomly divided into an observation and a control group,31 cases in each group.The patients in the observation group were treated with “Zhibian(BL54)to Shuidao(ST28)” acupuncture technique,combined with Taixi(KI3)and Mingmen(GV4),and the acupuncture was performed once every other day for 30 minutes each time.The control group was treated with estrogen progestogen sequential therapy(HRT).Both groups took 4 weeks as a course of treatment for 3 courses of treatment.The changes of TCM syndrome scores,serum levels of follicle stimulating hormone(FSH)and estradiol(E2)before and after treatment were recorded and compared,and the safety of the two kinds of therapies were evaluated at the same time.Results:Compared to pre-treatment,the TCM syndrome scores of the two groups of patients were reduced(P<0.05),moreover the observation group was lower than another group(P<0.05).The level of E2 has increased(P<0.05),and there is no statistically difference between the groups(P>0.05); the total effective rate of observation group is 90.32%,which is higher than that in the control group(P<0.05),the adverse event occurrence rate in the observation group was 3.23%,which was lower than 24.14% of the control group(P<0.05).Conclusion:Acupuncture of “Zhibian(BL54)to Shuidao(ST28)” has good effect on POI,and it has more advantageous not only in improving clinical symptoms of kidney deficiency type but also in safety than the western medicine group.

参考文献/References:

[1] 谢幸,孔北华,段涛.妇产科学[M].9版.北京:人民卫生出版社,2018:357-359.
[2] 王亚如,苏健,狄晓倩,等.卵巢早衰的研究进展[J].医学综述,2019,25(19):3895-3899.
[3] 郑晨思,杨会生,郝铭昭,等.年龄对针灸治疗早发性卵巢功能不全疗效影响的真实世界研究[J].中华中医药杂志,2022,37(8):4641-4646.
[4] 冀来喜.针灸优势技术组合方案治疗疑难病症体会[J].中国针灸,2019,39(1):73-76.
[5] 金晓飞,闫婧,赵季宇,等.“秩边透水道”针法对早发性卵巢功能不全大鼠肿瘤坏死因子相关凋亡诱导配体及其受体表达的影响[J].针刺研究,2023,48(3):259-266,280.
[6] 陈子江,田秦杰,乔杰,等.早发性卵巢功能不全的临床诊疗中国专家共识[J].中华妇产科杂志,2017,52(9):577-581.
[7] 张玉珍.中医妇科学[M].2版.北京:中国中医药出版社,2007:70-96.
[8] 中华中医药学会.中医妇科临床诊疗指南[M].北京:中国中医药出版社,2019:85-95.
[9] 国家食品药品监督管理总局.中药新药临床研究指导原则[M].北京:中国医药出版社,2002:243.
[10] 郗红燕,张杨,赵小萱,等.卵巢早衰病理机制最新研究进展[J].辽宁中医药大学学报,2019,21(12):103-106.
[11] 俞菊珍.女性尿液中邻苯二甲酸盐代谢物水平与卵巢早衰和生殖激素相关性研究[J].陕西医学杂志,2022,51(1):100-102,110.
[12] ARMENI E,PASCHOU S A,GOULIS D G,et al.Hormone therapy regimens for managing the menopause and premature ovarian insufficiency[J].Best Pract Res Clin Endocrinol Metab,2021,35(6):101561.
[13] 王林,段利利,崔瑞红,等.联合应用唑来膦酸治疗卵巢早衰继发骨质疏松疗效观察[J].陕西医学杂志,2015,44(11):1533-1535.
[14] 曹金翔,吴洁.早发性卵巢功能不全激素补充治疗利弊评价[J].中国实用妇科与产科杂志,2020,36(3):227-230.
[15] 李娟,徐琳,高洋.卵巢早衰病因机制与治疗研究进展及现状[J].中国医药科学,2021,11(2):58-61.
[16] 何佳宁,王佩娟.中药治疗早发性卵巢功能不全机制研究进展[J].陕西中医,2022,43(10):1481-1483,1486.
[17] 陆莎莎,常韦,刘明敏,等.李伟莉名中医治疗早发性卵巢功能不全经验[J].陕西中医,2021,42(4):510-513.
[18] 刘云婷,王盛春,纪培元,等.针灸治疗早发性卵巢功能不全的临床研究进展[J].中国性科学,2023,32(3):139-142.
[19] 王海军,曹玉霞,姬俊强,等.“秩边透水道”针法治疗女性压力性尿失禁:随机对照研究[J].中国针灸,2020,40(10):1061-1064.
[20] 刘宝贵,冀来喜,郝重耀,等.秩边透水道针法治疗慢性前列腺炎的解剖学基础[J].中国针灸,2001,15(2):27-29.
[21] 储开博,杨李旺,何丽清.“秩边透水道”穴周解剖关系及其治疗术后尿潴留机理探讨[J].中国中医药信息杂志,2009,16(4):98-99.
[22] 丘维钰,郜洁,高飞霞,等.“肾-天癸-冲任-胞宫”生殖轴的研究进展[J].广州中医药大学学报,2017,34(6):945-947.
[23] 伍琴,张韫玉,刘慧萍,等.尤昭玲教授治疗早发性卵巢功能不全经验[J].陕西中医,2021,42(7):941-943.
[24] 迪丽娜热?阿不都热西提,刘映雪,韩璐.以肾论治早发性卵巢功能不全的中医研究进展[J].新疆中医药,2023,41(2):108-112.
[25] 肖玉凤,翟红利,史碧云,等.中西医结合治疗不孕症300例[J].陕西中医,2003,24(5):414.

相似文献/References:

[1]陆莎莎,常 韦,刘明敏,等.李伟莉名中医治疗早发性卵巢功能不全经验[J].陕西中医,2021,(4):510.[doi:DOI:10.3969/j.issn.1000-7369.2020.04.028]
　LU Shasha,CHANG Wei,LIU Mingmin,et al.Experience of LI Weili in treating premature ovarian insufficiency[J].,2021,(2):510.[doi:DOI:10.3969/j.issn.1000-7369.2020.04.028]
[2]伍 琴,张韫玉,刘慧萍,等.尤昭玲教授治疗早发性卵巢功能不全经验[J].陕西中医,2021,(7):941.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.035]
[3]凌丹凤,马丽然.补肾活血除湿法治疗早发性卵巢功能不全不孕症临床研究[J].陕西中医,2021,(12):1717.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.016]
　LING Danfeng,MA Liran.Clinical observation on the treatment of early-onset ovarian insufficiency infertility with Bushen Huoxue Chushi method[J].,2021,(2):1717.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.016]
[4]何佳宁,王佩娟.中药治疗早发性卵巢功能不全机制研究进展[J].陕西中医,2022,(10):1481.[doi:DOI:10.3969/j.issn.1000-7369.2022.10.040]
　HE Jianing,WANG Peijuan.Research progress on the mechanism of traditional Chinese medicine in the treatment of premature ovarian insufficiency[J].,2022,(2):1481.[doi:DOI:10.3969/j.issn.1000-7369.2022.10.040]

备注/Memo

备注/Memo:
基金项目:国家科技支撑计划项目(2013BAI05B08); 山西省自然科学基金资助项目(201901D111399); 山西中医药大学校级课题(2019PY-034)
更新日期/Last Update: 2024-02-07